New Teva Generics
Theophylline Extended-Release Tablets
- Launch Date:
- 1/27/2023
Sorafenib Tablets, USP
- Brand Equivalent:
- Nexavar® tablets
- Launch Date:
- 1/3/2023
Lubiprostone Capsules
- Brand Equivalent:
- Amitiza® capsules
- Launch Date:
- 1/3/2023
Tasimelteon Capsules
- Brand Equivalent:
- Hetlioz® capsules
- Launch Date:
- 12/29/2022
Icosapent Ethyl Capsules
- Brand Equivalent:
- Vascepa® Capsules
- Launch Date:
- 12/15/2022
- New Strength:
- 1 g
Penciclovir Cream
- Brand Equivalent:
- Denavir® Cream
- Launch Date:
- 11/14/2022
Naproxen Sodium Extended-Release Tablets
- Brand Equivalent:
- Naprelan® Controlled-Release Tablets
- Launch Date:
- 11/1/2022
- New Strength:
- 750 mg
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution
- Brand Equivalent:
- Combigan®
- Launch Date:
- 10/7/2022
Levothyroxine Sodium Tablets, USP
- Brand Equivalent:
- Synthroid®
- Launch Date:
- 9/21/2022
Pantoprazole Sodium for Injection
- Brand Equivalent:
- Protonix® I.V. (pantoprazole sodium) for Injection
- Launch Date:
- 9/9/2022
Tacrolimus Ointment
- Brand Equivalent:
- Protopic® (tacrolimus) Ointment
- Launch Date:
- 9/9/2022
Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals)
- Brand Equivalent:
- Macrobid® (Nitrofurantoin Capsules, USP) (monohydrate/macrocrystals)
- Launch Date:
- 9/9/2022
Mycophenolate Mofetil Tablets
- Brand Equivalent:
- CellCept® (mycophenolate mofetil) Tablets
- Launch Date:
- 9/9/2022